News
API and Eli Lilly launch nationwide CME programme to strengthen obesity care among indian physicians
The Obesity Gurukul initiative will train over 20,000 healthcare professionals across India through a hybrid education model ...
The initiative will provide practical insights into understanding of obesity pathophysiology and its management.
Lilly partners with API to launch ‘Obesity Gurukul’, a flagship continuing medical education program
Lilly partners with API to launch ‘Obesity Gurukul’, a flagship continuing medical education program: Our Bureau, Bengaluru Monday, July 14, 2025, 15:20 Hrs [IST] Eli Lilly an ...
Stockhead on MSN2d
ScoPo’s Powerplays: Morgans expert Iain Wilkie fills in to talk health stocks as CSL leads a 5pc rallyMorgans healthcare and life sciences expert Iain Wilkie explains what the movers and shakers have been doing in health and ...
An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...
A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring to U.S. biopharma.
Eli Lilly and Company (NYSE:LLY) is one of the high-margin pharma stocks to buy now. Eli Lilly and Company (NYSE:LLY) is set ...
Eli Lilly is advancing its Phase 2 clinical trial to test LY3841136 for weight management in obese and overweight adults.
ABP News on MSN4d
CBSE Pushes ‘Oil Boards’ In Schools To Tackle Obesity Crisis Among Students; Details HereThe Central Board of Secondary Education (CBSE) has issued a fresh directive urging schools to install 'Oil Boards' on campuses in an effort to cultivate healthy habits among students. The initiative, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback